Assuntos
Antibacterianos/farmacologia , Animais , Antibacterianos/metabolismo , Clorobenzenos , Cresóis/metabolismo , Cresóis/farmacologia , Resistência Microbiana a Medicamentos , Cinética , Masculino , Testes de Sensibilidade Microbiana , Microscopia Eletrônica , Ratos , Ratos Endogâmicos , SupositóriosRESUMO
In vitro assays showed that low concentrations (5--10 and 20 microgram/ml) of the antimicrobial paromomycin sulfate are able to block or diminish significantly the transfer of the tetracycline resistance R-factor between Escherichia coli and Salmonella pullorum. This observation is important because it offers the possibility of preventing the formation of tetracycline-resistant pathogens, a limiting factor of tetracycline use in both human and veterinary medicine.
Assuntos
Escherichia coli/efeitos dos fármacos , Paromomicina/farmacologia , Fatores R/efeitos dos fármacos , Salmonella/efeitos dos fármacos , Tetraciclinas/farmacologia , Colífagos/isolamento & purificação , Conjugação Genética , Depressão Química , Escherichia coli/genética , Salmonella/genéticaRESUMO
During the recent epidemic of meningitis in Brazil, 1974, bacteriological and antibiotic sensitivity investigations were performed on 302 strains of Neisseria meningitidis, isolated from meningitis patients from the São Paulo and Rio de Janeiro districts in the first half of 1974. The experiments have shown that 58% of the strains belong to the serological type A, 25% belong to type C and the remaining 17% to a group designated 'untypable' in that they did not react with the diagnostic antisera A, B, C, and D. Antibiotic sensitivity tests in vitro have made evident that, independently of the serological type, 89.8% of the 302 strains were inhibited by 10 mug/ml of a long-acting sulfonamide (sulfamethoxypyrazine, SMP), that is, by levels easily reached in the CSF during a normal prophylactic or therapeutic treatment.
Assuntos
Antibacterianos/farmacologia , Neisseria meningitidis/efeitos dos fármacos , Sulfametoxipiridazina/farmacologia , Brasil , Humanos , Meningite/microbiologia , Testes de Sensibilidade Microbiana , SorotipagemRESUMO
During the cholera epidemic in 1973, nine contact carriers of Vibrio cholerae El Tor serotype Ogawa were identified in a family from Naples as well as six others coming from different parts of the city or its surroundings. All the subjects were admitted to the quarantine ward of the 'Cotugno Hospital' (Naples) in which they remained continuously for 14 or 16 days. During this time these bacteriologically confirmed carriers were treated orally with a long-acting sulphonamide (sulphamethoxypyrazine, Kelfizine). Coprocultural examinations carried out on each patient on average 7 times after the treatment over a period of 6 months, proved the absence of V. cholerae. Serological tests also showed high levels of agglutinating and vibriocidal anticholera Ogawa antibodies in two unvaccinated carriers.
Assuntos
Cólera/tratamento farmacológico , Sulfaleno/uso terapêutico , Sulfanilamidas/uso terapêutico , Adolescente , Adulto , Idoso , Técnicas Bacteriológicas , Portador Sadio , Criança , Pré-Escolar , Cólera/epidemiologia , Cólera/genética , Avaliação de Medicamentos , Fezes/microbiologia , Feminino , Humanos , Itália , Masculino , Pessoa de Meia-Idade , Sorotipagem , Fatores de Tempo , Vibrio cholerae/isolamento & purificaçãoRESUMO
Some in vivo experiments of therapeutic activity in severe experimental infection (intracranial) in the mouse due to different strains of Mycoplasma proved the high efficacy of the antibiotic aminosidine when administered subcutaneously at the dose of 30 mg/kg and have also demonstrated that oral treatment is moderately effective against Mycoplasma hominis 2. Sensitivity test carried out in vitro on the same Mycoplasma strains confirmed the bactericidal activity of aminosidine. These experiments have therefore shown that the therapeutic spectrum of aminosidine, which includes Gram-positive, Gram-negative, acid-fast bacteria and some protozoa, may be enlarged to include the genus Mycoplasma. For this reason the antibiotic can find a useful application in the treatment of primary atypical neumonia. In addition, from a clinical research point of view, aminosidine may constitute a promising tool for the treatment of different illnesses in which Mycoplasma have been described as important co-factors of pathogenicity in man.
Assuntos
Mycoplasma/efeitos dos fármacos , Paromomicina/farmacologia , Animais , Meios de Cultura , Camundongos , Testes de Sensibilidade Microbiana , Microscopia Eletrônica , Mycoplasma/ultraestrutura , Infecções por Mycoplasma/tratamento farmacológico , Paromomicina/uso terapêuticoRESUMO
The antimycoplasma activity (bacteriostatic and bactericidal) of daunomycin and adriamycin has been tested on 14 strains in liquid and solid medium. The minimal inhibitory concentration (MIC) values of daunomycin and tetracycline have resulted of the same greatness, while those regarding adriamycin are lightly greater.
Assuntos
Daunorrubicina/farmacologia , Doxorrubicina/farmacologia , Mycoplasma/efeitos dos fármacos , Tetraciclina/farmacologia , Parede CelularAssuntos
Cardiopatia Reumática/imunologia , Infecções Estreptocócicas/imunologia , Streptococcus , Animais , Proteínas de Bactérias/análise , Enzimas/análise , Humanos , Ácido Hialurônico/análise , Peptídeos/análise , Polissacarídeos Bacterianos/análise , Streptococcus/análise , Streptococcus/imunologia , Streptococcus/patogenicidade , Toxinas Biológicas/análiseRESUMO
127 pathogenic, opportunist and saprophytic strains isolated from patients and material in a Milanese oncological department were tested. An association of Ampicillin and Dicloxacillin ana (Diamplicil) proved effective against all strains, particularly Gram-negative bacteria notoriously responsible for hospital infections. A statistically inferior performance was observed for Rifampicin and Cephaloridine.